ND

Neetu Dwivedi

Director Director DIN 09475457
DIN 09475457 First appointment Jan 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2022
Shareholding value Locked Premium profile

About Neetu Dwivedi

Data last updated:

Neetu Dwivedi has 4 years in corporate governance. Formerly with 1 company, such as Bryopetris Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09475457
Primary Designation Director
First Appointment 22 Jan 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Additional Director22 Jan 20222020Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bryopetris Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Neetu Dwivedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neetu Dwivedi

Neetu Dwivedi has 4 years in corporate governance. Formerly with 1 company, such as Bryopetris Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Neetu Dwivedi is associated with 0 companies as a director.

Neetu Dwivedi has expertise in General Business.

Neetu Dwivedi has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available